STOCK TITAN

BiomX (PHGE) investors back all proposals at April 10 special meeting

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

BiomX Inc. held a special meeting of stockholders on April 10, 2026, where all proposals described in its March 25, 2026 proxy statement were approved. As of the March 23, 2026 record date, there were 6,543,516 shares of common stock outstanding and entitled to the same number of votes.

Holders representing 3,409,604 votes were present in person or by proxy. On the proposals presented, 3,395,917 votes were cast for, 5,009 against, and 8,678 abstained, with no broker non-votes and no need to adjourn the meeting.

Positive

  • None.

Negative

  • None.
Item 5.07 Submission of Matters to a Vote of Security Holders Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Shares entitled to vote 6,543,516 shares Common stock outstanding as of March 23, 2026 record date
Votes represented at meeting 3,409,604 votes Votes present in person or by proxy at April 10, 2026 special meeting
Votes for proposals 3,395,917 votes Votes cast in favor of each proposal at the special meeting
Votes against proposals 5,009 votes Votes cast against each proposal at the special meeting
Abstentions 8,678 votes Votes marked abstain on each proposal at the special meeting
special meeting of stockholders financial
"BiomX Inc. held a special meeting of stockholders on April 10, 2026"
A special meeting of stockholders is an unscheduled gathering called to let shareholders vote on specific, often urgent company decisions—like mergers, major asset sales, changes to the board, or amendments to governing rules. Think of it as an emergency town hall where owners cast ballots in person or by mail/online; outcomes can materially change a company’s strategy, control or value, so investors pay close attention and may need to vote or adjust holdings accordingly.
record date financial
"As of the close of business on March 23, 2026, the record date for the Special Meeting"
The record date is the specific day when a company determines which shareholders are eligible to receive a dividend or participate in an upcoming vote. It’s like a cutoff date; if you own the stock on that day, you get the benefits or voting rights. This date matters because it decides who qualifies for certain company benefits.
broker non-votes financial
"There were no broker non-votes at the Special Meeting because under applicable rules"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
non-routine matters financial
"all proposals presented at the Special Meeting were considered non-routine matters"
definitive proxy statement financial
"proposals set forth in the Company’s definitive proxy statement filed with the Securities and Exchange Commission"
A Definitive Proxy Statement is a detailed document that a company sends to its shareholders before a big meeting, like voting on important decisions. It explains what's being voted on and gives important information so shareholders can make informed choices. It matters because it helps shareholders understand and participate in key company decisions.
false 0001739174 0001739174 2026-04-10 2026-04-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

CURRENT REPORT

 

Pursuant to Section 13 or Section 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 10, 2026

 

BIOMX INC.
(Exact name of registrant as specified in its charter)

 

Delaware   001-38762   82-3364020
(State or other jurisdiction of
incorporation or organization)
  (Commission File Number)   (IRS Employer
Identification Number)

 

850 New Burton Road, Suite 201, Dover, DE 19904

(Address of principal executive offices)

 

972 52 437 4900

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.0001 par value per share   PHGE   NYSE American

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 
 

  

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

On April 10, 2026, BiomX Inc. (the “Company”) held a special meeting of stockholders (the “Special Meeting”) to vote on the proposals set forth in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on March 25, 2026. As of the close of business on March 23, 2026, the record date for the Special Meeting, there were (i) 6,543,516 shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”) outstanding and entitled to an aggregate of 6,543,516 votes. Holders of the Company’s Common Stock with a total aggregate voting power of 3,409,604 votes were present in person or represented by proxy at the Special Meeting. There were no broker non-votes at the Special Meeting because under applicable rules, all proposals presented at the Special Meeting were considered non-routine matters.

 

The matters described below were submitted to a vote of the holders of the Company’s Common Stock at the Special Meeting. Each proposal is described in detail in the Company’s Proxy Statement. All proposals were approved by the Company’s stockholders.

 

1. Proposal to approve the BiomX Inc. 2026 Equity Incentive Plan, which provides for the issuance of up to 1,390,000 shares of Common Stock, with an annual automatic increase (of 4% of the total number of shares of Common Stock outstanding on December 31 of the preceding calendar year for a period of ten (10) years.

 

For   Against   Abstain
 3,395,917      5,009  

 8,678

 

 

2. Approval of a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of Proposal No. 1 .

 

For   Against   Abstain
3,395,917   5,009   8,678 

 

 

No adjournment of the Special Meeting was necessary. The results reported above are final voting results. 

 

1 
 

  

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  BIOMX INC.
     
Date: April 10, 2026 By: /s/ Michael Oster
  Name: Michael Oster
  Title: Chief Executive Officer

 

 

2

 

 

FAQ

What did BiomX Inc. (PHGE) announce in this 8-K filing?

BiomX Inc. reported the final results of a special stockholder meeting held on April 10, 2026. All proposals described in its March 25, 2026 proxy statement were approved, with detailed vote counts and confirmation that no adjournment was required.

How many BiomX (PHGE) shares were entitled to vote at the special meeting?

A total of 6,543,516 shares of BiomX common stock were outstanding and entitled to vote as of the March 23, 2026 record date. Each share represented one vote, giving stockholders an aggregate of 6,543,516 possible votes at the special meeting.

What level of turnout did BiomX (PHGE) have at the April 10, 2026 special meeting?

Stockholders representing 3,409,604 votes were present in person or by proxy at the special meeting. This figure shows how many of the 6,543,516 eligible votes actually participated in deciding the proposals presented for approval.

How did BiomX (PHGE) stockholders vote on the special meeting proposals?

For each proposal, 3,395,917 votes were cast in favor, 5,009 were cast against, and 8,678 abstained. These results indicate clear approval of the proposals submitted to stockholders, with relatively few votes opposed and a small number of abstentions.

Were there any broker non-votes at the BiomX (PHGE) special meeting?

There were no broker non-votes at the special meeting. All proposals were classified as non-routine matters under applicable rules, meaning brokers could not vote without instructions, and thus every share counted in the turnout reflected directed voting.

Did BiomX (PHGE) need to adjourn its April 10, 2026 special meeting?

No adjournment of the special meeting was necessary. The company reported that the proposals received sufficient support at the scheduled time, allowing the meeting to conclude with final vote results recorded and no need for a later reconvened session.

Filing Exhibits & Attachments

3 documents